DK1227817T3 - Ciclesonid-holdigt vandigt farmaceutisk præparat - Google Patents

Ciclesonid-holdigt vandigt farmaceutisk præparat

Info

Publication number
DK1227817T3
DK1227817T3 DK00969967T DK00969967T DK1227817T3 DK 1227817 T3 DK1227817 T3 DK 1227817T3 DK 00969967 T DK00969967 T DK 00969967T DK 00969967 T DK00969967 T DK 00969967T DK 1227817 T3 DK1227817 T3 DK 1227817T3
Authority
DK
Denmark
Prior art keywords
ciclesonide
pharmaceutical composition
containing aqueous
aqueous pharmaceutical
composition
Prior art date
Application number
DK00969967T
Other languages
English (en)
Inventor
Atsuhiro Nagano
Yoshihisa Nishibe
Kazuya Takanashi
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17856339&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1227817(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Application granted granted Critical
Publication of DK1227817T3 publication Critical patent/DK1227817T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK00969967T 1999-10-20 2000-10-20 Ciclesonid-holdigt vandigt farmaceutisk præparat DK1227817T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP29818699 1999-10-20
PCT/JP2000/007351 WO2001028563A1 (en) 1999-10-20 2000-10-20 Ciclesonide-containing aqueous pharmaceutical composition

Publications (1)

Publication Number Publication Date
DK1227817T3 true DK1227817T3 (da) 2004-11-15

Family

ID=17856339

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00969967T DK1227817T3 (da) 1999-10-20 2000-10-20 Ciclesonid-holdigt vandigt farmaceutisk præparat

Country Status (36)

Country Link
US (2) US8383611B1 (da)
EP (1) EP1227817B1 (da)
JP (1) JP4856338B2 (da)
KR (1) KR100705372B1 (da)
CN (1) CN1198623C (da)
AR (1) AR026073A1 (da)
AT (1) ATE270107T1 (da)
AU (1) AU776587B2 (da)
BG (1) BG65799B1 (da)
BR (1) BRPI0014880B8 (da)
CA (1) CA2388325C (da)
CO (1) CO5251406A1 (da)
CZ (1) CZ297780B6 (da)
DE (1) DE60011924T2 (da)
DK (1) DK1227817T3 (da)
EA (1) EA005201B1 (da)
ES (1) ES2223595T3 (da)
HK (1) HK1051003A1 (da)
HR (1) HRP20020345B1 (da)
HU (1) HU228894B1 (da)
IL (2) IL148725A0 (da)
ME (1) ME00568A (da)
MX (1) MXPA02003975A (da)
MY (1) MY121175A (da)
NO (1) NO327379B1 (da)
NZ (1) NZ518299A (da)
PE (1) PE20010713A1 (da)
PL (1) PL197537B1 (da)
PT (1) PT1227817E (da)
RS (1) RS50345B (da)
SI (1) SI1227817T1 (da)
SK (1) SK286194B6 (da)
TR (1) TR200200831T2 (da)
TW (1) TWI269655B (da)
WO (1) WO2001028563A1 (da)
ZA (1) ZA200203078B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR026073A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
BRPI0312377A8 (pt) * 2002-07-02 2015-12-15 Altana Pharma Ag Suspensão aquosa estéril contendo ciclesonida
CA2495830C (en) 2002-08-30 2012-08-21 Altana Pharma Ag The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
WO2004052374A1 (en) 2002-12-12 2004-06-24 Altana Pharma Ag Combination medicament
MY143936A (en) 2003-03-27 2011-07-29 Nycomed Gmbh Process for preparing crystalline ciclesonide with defined particle size
EP1670482B2 (en) 2003-09-16 2022-06-29 Covis Pharma B.V. Use of ciclesonide for the treatment of respiratory diseases
PE20050941A1 (es) * 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
EP1827378A2 (en) * 2004-11-17 2007-09-05 Government of The United States of America, as represented by Secretary, Department of Health and Human Services Steroid formulation and methods of treatment using same
JP5661985B2 (ja) 2006-12-27 2015-01-28 帝人ファーマ株式会社 無菌性水性懸濁製剤
DK2262506T3 (da) 2008-03-11 2014-06-10 Alcon Res Ltd Meget flokkulerede triamcinolonacetonid-suspensioner med lav viskositet til intravitreal injektion

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4271143A (en) 1978-01-25 1981-06-02 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage
CH657779A5 (de) 1982-10-05 1986-09-30 Sandoz Ag Galenische zusammensetzungen enthaltend calcitonin.
AU572815B2 (en) 1982-12-29 1988-05-19 Armour Pharmaceutical Company Pharmaceutical calcitonin compositions for intranasal application
JPS59163313A (ja) 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
EP0501523B1 (en) 1983-11-14 1997-04-09 Columbia Laboratories, Inc. Bioadhesive compositions
GB8515132D0 (en) 1985-06-14 1985-07-17 British Nuclear Fuels Plc Measuring photosynthetic activities of plants
US5179079A (en) 1986-12-16 1993-01-12 Novo Nordisk A/S Nasal formulation and intranasal administration therewith
MY102411A (en) 1986-12-23 1992-06-17 Ciba Geigy Ag Nasal solutions
JPH0744940B2 (ja) 1986-12-24 1995-05-17 ライオン株式会社 口腔貼付用基材
US4802967A (en) 1987-04-08 1989-02-07 Andus Corporation Surface treatment of polymers
JPS63303931A (ja) 1987-06-05 1988-12-12 Sumitomo Pharmaceut Co Ltd 経鼻投与用成長ホルモン放出活性物質製剤
US4788220A (en) 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions
US5188826A (en) 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
US5192535A (en) 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
US5776493A (en) 1989-07-14 1998-07-07 Alza Corporation Oral osmotic device for delivery of nystatin with hydrogel driving member
ATE113841T1 (de) 1989-10-31 1994-11-15 Columbia Lab Inc Mittel zur feuchthaltung vaginalen gewebes.
US5147654A (en) 1990-07-23 1992-09-15 Alza Corporation Oral osmotic device for delivering nicotine
JPH078806B2 (ja) 1990-08-16 1995-02-01 旭化成工業株式会社 カルシトニン類含有経鼻投与用乳剤
GB9102579D0 (en) 1991-01-24 1991-03-27 Glaxo Group Ltd Compositions
GB9103824D0 (en) 1991-02-23 1991-04-10 Fisons Ag Formulation
AU668352B2 (en) 1991-04-03 1996-05-02 Keimowitz, Rudolph M.D. Suppression of thromboxane levels by percutaneous administration of aspirin
IT1250691B (it) * 1991-07-22 1995-04-21 Giancarlo Santus Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
US5200195A (en) 1991-12-06 1993-04-06 Alza Corporation Process for improving dosage form delivery kinetics
JP2860729B2 (ja) 1992-03-10 1999-02-24 エスエス製薬株式会社 プラノプロフェン懸濁シロップ剤
CA2101126A1 (en) 1992-08-03 1994-02-04 Yasushi Morita Preparation for local treatment
JP3047948B2 (ja) 1992-12-07 2000-06-05 株式会社ツムラ ペプチド類経鼻投与用組成物
US5340572A (en) 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
US5409703A (en) 1993-06-24 1995-04-25 Carrington Laboratories, Inc. Dried hydrogel from hydrophilic-hygroscopic polymer
JP2787131B2 (ja) 1993-07-30 1998-08-13 千寿製薬株式会社 水性懸濁液剤
US5540930A (en) 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
JP3781792B2 (ja) 1993-12-27 2006-05-31 千寿製薬株式会社 ジフルプレドナート含有点眼用懸濁液剤
JPH07188059A (ja) 1993-12-28 1995-07-25 Rohto Pharmaceut Co Ltd 歯周病治療剤
RU2102979C1 (ru) 1994-07-18 1998-01-27 Панкрушева Татьяна Александровна Средство для лечения гнойно-воспалительных процессов кожи и слизистых оболочек различной этиологии
US5726181A (en) 1995-06-05 1998-03-10 Bionumerik Pharmaceuticals, Inc. Formulations and compositions of poorly water soluble camptothecin derivatives
WO1997001337A1 (en) 1995-06-29 1997-01-16 Mcneil-Ppc, Inc. The combination of topical nasal antihistamines and topical nasal steroids
JP3098401B2 (ja) 1995-07-12 2000-10-16 株式会社エルティーティー研究所 経鼻投与用製剤
JP2791317B2 (ja) 1995-12-26 1998-08-27 株式会社三和化学研究所 多層フィルム製剤
PT943326E (pt) 1996-02-27 2003-12-31 Teijin Ltd Composicao em po para administracao nasal
US5976573A (en) 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
US5955097A (en) 1996-10-18 1999-09-21 Virotex Corporation Pharmaceutical preparation applicable to mucosal surfaces and body tissues
IT1286496B1 (it) 1996-11-20 1998-07-15 Leetrim Ltd Dublin Composizione farmaceutica orale ad attivita' antipiretica,analgesica ed antiinfiammatoria
FR2756739B1 (fr) 1996-12-05 2000-04-28 Astra Ab Nouvelle formulation de budesonide
SE9604486D0 (sv) 1996-12-05 1996-12-05 Astra Ab Novel formulation
TW503113B (en) 1997-01-16 2002-09-21 Senju Pharma Co Aqueous suspension for nasal administration
US6120752A (en) * 1997-05-21 2000-09-19 3M Innovative Properties Company Medicinal aerosol products containing formulations of ciclesonide and related steroids
JPH1121229A (ja) 1997-06-30 1999-01-26 Kyoto Yakuhin Kogyo Kk 抗真菌性外用製剤およびその製造方法
JP3386348B2 (ja) 1997-10-30 2003-03-17 帝人株式会社 鼻腔内投与用水性懸濁製剤
JP3386349B2 (ja) 1997-10-30 2003-03-17 帝人株式会社 水性懸濁医薬品組成物
JPH11130658A (ja) 1997-10-30 1999-05-18 Teijin Ltd 水性懸濁医薬品組成物
SE9704186D0 (sv) * 1997-11-14 1997-11-14 Astra Ab New composition of matter
CA2318642A1 (en) 1998-01-22 1999-07-29 Santen Pharmaceutical Co., Ltd. Fluorometholone ophthalmic suspension
SE514128C2 (sv) * 1998-03-17 2001-01-08 Pharmalink Ab Användning av en glukokortikoid för framställning av ett läkemedel för behandling av glomerulonefrit
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US6124268A (en) * 1999-02-17 2000-09-26 Natreon Inc. Natural antioxidant compositions, method for obtaining same and cosmetic, pharmaceutical and nutritional formulations thereof
RU11829U1 (ru) 1999-05-05 1999-11-16 Специальное конструкторское бюро транспортного машиностроения (ОАО Спецмаш) Рабочая площадка для буровых установок
WO2001028517A1 (fr) 1999-10-20 2001-04-26 Teijin Limited Compositions therapeutiques aqueuses
AR026072A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
AR026073A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida

Also Published As

Publication number Publication date
AU776587B2 (en) 2004-09-16
AU7953200A (en) 2001-04-30
EP1227817A1 (en) 2002-08-07
MY121175A (en) 2005-12-30
TR200200831T2 (tr) 2002-07-22
US8383611B1 (en) 2013-02-26
BG65799B1 (bg) 2009-12-31
JP2003512330A (ja) 2003-04-02
CA2388325C (en) 2007-09-18
CO5251406A1 (es) 2003-02-28
NO20021866L (no) 2002-04-19
MXPA02003975A (es) 2003-09-25
CN1379673A (zh) 2002-11-13
ME00568B (me) 2011-12-20
NO20021866D0 (no) 2002-04-19
PE20010713A1 (es) 2001-07-13
KR20020060205A (ko) 2002-07-16
IL148725A0 (en) 2002-09-12
EA005201B1 (ru) 2004-12-30
TWI269655B (en) 2007-01-01
DE60011924D1 (de) 2004-08-05
HRP20020345A2 (en) 2005-10-31
CZ20021284A3 (cs) 2002-07-17
IL148725A (en) 2006-12-31
EA200200383A1 (ru) 2002-10-31
PL197537B1 (pl) 2008-04-30
ATE270107T1 (de) 2004-07-15
BRPI0014880B8 (pt) 2021-05-25
CA2388325A1 (en) 2001-04-26
YU28102A (sh) 2004-12-31
BRPI0014880B1 (pt) 2015-08-11
NZ518299A (en) 2004-03-26
HUP0203756A3 (en) 2004-06-28
RS50345B (sr) 2009-11-10
AR026073A1 (es) 2002-12-26
PL356190A1 (en) 2004-06-14
DE60011924T2 (de) 2005-07-07
US20130095146A1 (en) 2013-04-18
SI1227817T1 (en) 2004-12-31
HK1051003A1 (en) 2003-07-18
BG106517A (en) 2002-12-29
CZ297780B6 (cs) 2007-03-28
WO2001028563A1 (en) 2001-04-26
KR100705372B1 (ko) 2007-04-11
CN1198623C (zh) 2005-04-27
SK286194B6 (sk) 2008-05-06
ES2223595T3 (es) 2005-03-01
BR0014880A (pt) 2002-06-11
HUP0203756A2 (en) 2003-05-28
ME00568A (en) 2011-12-20
HU228894B1 (hu) 2013-06-28
JP4856338B2 (ja) 2012-01-18
SK6932002A3 (en) 2002-09-10
ZA200203078B (en) 2003-01-29
HRP20020345B1 (en) 2006-12-31
NO327379B1 (no) 2009-06-22
PT1227817E (pt) 2004-11-30
EP1227817B1 (en) 2004-06-30

Similar Documents

Publication Publication Date Title
NO20015175D0 (no) Farmasöytisk sammensetning
ITMI20001450A0 (it) Nuova composizione farmaceutica
PT1242087E (pt) Composicoes farmaceuticas
DK1524266T3 (da) Farmaceutisk sammensætning
ATE392890T1 (de) Hydrogel-gesteuerte dosierungsform
ITTO20010008A0 (it) Formulazione farmaceutica
FI20105657A (fi) Farmaseuttisia koostumuksia
AR028204A1 (es) Composiciones farmaceuticas electrohiladas
ITMI20010748A0 (it) Composizioni farmaceutiche
EE05020B1 (et) Glburiidi ravimkoostis
BR0013417B1 (pt) composiÇço aquosa.
NO20015670L (no) Forbedrede farmasöytiske formuleringer
NO20022606D0 (no) Farmasöytiske kombinasjoner
PT1210085E (pt) Solucoes farmaceuticas de levosimendano
NO20026123L (no) Farmasöytiske sammensetninger
PT1239832E (pt) Composicoes farmaceuticas
NO20014926L (no) Farmasöytiske forbindelser
NO20031095L (no) Farmasoytiske sammensetninger
DK1227817T3 (da) Ciclesonid-holdigt vandigt farmaceutisk præparat
FI4488U1 (fi) Farmaseuttinen koostumus
AR025867A1 (es) Formulacion portasdora farmaceutica
NO20016430L (no) Farmasöytisk kompleks
NO20021036D0 (no) Farmasöytisk preparat
EE200200689A (et) Ravimkoostised
DK1060749T3 (da) Vandigt farmaceutisk præparat indeholdende Tezosentan